James E. Flynn Buys 70,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock

Bicara Therapeutics Inc. (NASDAQ:BCAX) major shareholder James E. Flynn purchased 70,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 17th. The stock was acquired at an average cost of $18.00 per share, for a total transaction of $1,260,000.00. Following the transaction, the insider now owns 897,587 shares in the company, valued at approximately $16,156,566. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Bicara Therapeutics Price Performance

Shares of BCAX opened at $25.73 on Thursday. Bicara Therapeutics Inc. has a 52 week low of $21.05 and a 52 week high of $27.94.

Bicara Therapeutics Company Profile

Bicara Therapeutics Inc, a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors.